ThinkPatternGet the app
Story
POLITICS · NOV 17, 2026

White House Withdraws Heidi Overton's FDA Nomination

The White House withdrew Dr. Heidi Overton's nomination to lead the FDA after she faced opposition from Senate Republicans and anti-abortion groups.

The White House withdrew the nomination of Heidi Overton to lead the Food and Drug Administration on Tuesday, one day before a scheduled vote by the Senate Health, Education, Labor and Pensions Committee. Overton, a physician and deputy director of the White House Domestic Policy Council, reportedly lacked the necessary Republican support to advance.

Committee Chairman Bill Cassidy and other GOP lawmakers raised concerns over Overton's scientific independence and her support for flavored vaping products. Cassidy specifically described her stance on breaking up combination childhood vaccines as "almost disqualifying." Additionally, the anti-abortion group Susan B. Anthony Pro-Life America and members of the Make America Healthy Again movement opposed her nomination, with the former arguing she was not sufficiently opposed to the abortion pill mifepristone.

While the administration cited a lack of Senate support for the withdrawal, Bill Cassidy disputed this claim, asserting that Overton likely would have passed both the committee and the full Senate. He indicated that some anti-abortion senators were simply seeking final assurances on life issues before proceeding.

Health Secretary Robert F. Kennedy Jr. has reportedly contacted former Senator Roger Marshall as a potential replacement for the role. The FDA continues to be led by acting Commissioner Kyle Diamantas.


Reported across 193 outlets
Actors
Donald TrumpBill CassidyRobert F. Kennedy Jr.Food and Drug AdministrationSusan B. Anthony Pro-Life America

Keep reading in the app

The full story and every source, free in the app.